TRAF6 and myelodysplastic syndrome: The RNA sequencing analysis of TRAF6-overexpressing HSCs showed that, despite the elevated TRAF6 levels, these cells did not exhibit a heightened inflammatory state compared to what was initially observed in MDS patients.